No outgrowth of chondrocytes from non-digested particulated articular cartilage embedded in commercially available fibrin matrix: an in vitro study
© Andjelkov et al. 2016
Received: 15 December 2015
Accepted: 1 February 2016
Published: 16 February 2016
Commercially available fibrin is routinely being used as both a matrix in certain cartilage repair techniques and a method for scaffold fixation. Chondrocytes from non-digested particulated cartilage fragments are proposed as a possible source for new cartilage tissue formation in some operative techniques. The goal of this study was to test that chondrocytes from particulated articular cartilage embedded in fibrin have an active role in the process of cartilage repair, as well as if commercially available fibrin should be used as a suitable matrix.
Articular cartilage was obtained from patients undergoing total knee replacement surgery. The biopsies were particulated in small, 1–2-mm3 pieces and embedded in fibrin. Two groups were compared in our study, particulated articular cartilage with and without collagenase treatment. The specimens were analyzed by optical microscopy after 2–5 weeks of cultivation in a special construct embedded in a cell culture medium containing particulated cartilage embedded in fibrin in the upper phase and cancellous bone in the lower phase under the perforated nylon membrane.
None of the biopsies taken from four different patients showed the outgrowth of chondrocytes or bone marrow-originated cells into the fibrin matrix in our experimental model.
It has been shown in our experimental model in vitro little to support the theory that articular chondrocytes from particulated articular cartilage embedded in fibrin have an active role in cartilage repair in its early stage.
A novel technique based on particulated cartilage embedded in a suitable carrier, fibrin matrix among others, has been recently introduced as an alternative treatment in cartilage repair. Basically, there are two different variants of the same technique: one using autologous articular cartilage fragments and the other cartilage fragments from juvenile allograft donor. These techniques are known as the Cartilage Autograft Implantation System (CAIS; DePuy/Mitek, Raynham, MA) and DeNovo Natural Tissue (NT; ISTO, St. Louis, MO) [1, 2].
The authors have reported that in laboratory and animal models, both techniques have shown the ability of transplanted cartilage cells to migrate from an extracellular matrix, divide, and form a new hyaline-like cartilage tissue matrix that integrates with the surrounding host tissue . In another method for cartilage repair, namely, autologous chondrocyte implantation (ACI), it has been postulated that cartilage pieces have to be first treated with enzymes, i.e., collagenase, in order to “release” chondrocytes from the matrix, which can then migrate, multiply, and eventually create a new cartilage-like tissue formation .
The goal of this study was to test if chondrocytes are able to “escape” the cartilage without enzymatic digestion and, by doing so, may have an active role in new cartilage tissue formation, as well as if fibrin can be used as a suitable matrix in cartilage repair techniques.
Cartilage and cancellous bone biopsies were obtained from four patients undergoing total knee replacement surgery. These patients had predominantly medial gonarthrosis, and consequently, a macroscopically normal cartilage, as judged by the surgeon, could be found in the lateral compartment of the knee. The cartilage biopsies were placed in a sterile 12-ml tube on 37 °C and in a matter of hours transferred to Dulbecco’s Modified Eagle’s Medium/Nutrient Mixture F-12 Ham (Cat. Nr. D8437, Sigma-Aldrich). Prior to that, amphotericin B and gentamicin were added to the medium in final concentrations of 2.5 and 50 μg/ml, respectively. The cartilage biopsies were minced to 1–2-mm3 pieces. Approximately half of this cartilage was transferred to another sterile 12-ml tube containing collagenase diluted in a cell culture medium to a total concentration of 0.8 mg/ml (collagenase type XI, C-9407, Sigma-Aldrich). The rest of the cartilage fragments were left in the tube with the cell culture medium alone, and both were then placed into a cell incubator (37 °C and 5 % CO2) overnight. The cancellous bone biopsies were placed in a sterile 24-well plate containing the cell culture medium with added antibiotics and then left in the cell incubator overnight.
Ethical approvals and informed consents
The Regional Ethical Review Board in Uppsala, at Uppsala Universitet has approved the study, and informed consent was obtained from all the patients donating their cartilage specimens for the study.
In our experimental model in vitro, we have seen the outgrowth of articular chondrocytes only in those specimens which have been digested with collagenase. The articular chondrocytes from the particulated, but non-digested, cartilage fragments have not shown any tendency for outgrowth. This finding is quite opposite to the claim of some other authors, namely, the establishers of the abovementioned novel operative technique/s . According to these authors, the ability of articular chondrocytes to “escape” a cartilage has been proven in both laboratory and animal models . The enzymatic digestion of the cartilage with collagenase has been postulated as absolutely necessary for the migration of articular chondrocytes out of the cartilage and their multiplication, as done in ACI . A study showing goat articular chondrocyte outgrowth both in vitro and in vivo has been done . The presence of chondrocyte outgrowth in vitro has been evident after 15 days and increased at 1 and 2 months. The cartilage fragments in this study have been embedded in fibrin and loaded onto a scaffold composed of a hyaluronic acid (HA)-derived membrane in the lower phase and platelet-rich fibrin matrix (PRFM) in the superior phase . In our in vitro model, however, the human articular chondrocytes remained captured inside the fibrin matrix during the observed period of time, 2–5 weeks namely (Fig. 2). We have used neither HA-derived membrane nor PRFM, but still, it is a striking fact that we have not identified a single chondrocyte escaping the cartilage matrix. When digesting the cartilage fragments with collagenase overnight, the cells have escaped from the fragments, but a migration of cells into the fibrin matrix has not been observed either (Fig. 3). It has been suggested that a fibrin sealant promotes migration and proliferation of human articular chondrocytes in vitro . On the other side, it has been reported that human fibrin glue hampered the healing process in rabbits in a similar model to that previously described in the text [4, 6]. The difference between the first named study  and our study is that we have used primary cartilage explants, non-digested as well, while primary chondrocyte culture has been used in the other case . However, not even the cancellous bone-derived cells have penetrated the fibrin matrix, which speaks more in favor of fibrin-hampered chondrocyte migration rather than fibrin sealant promotion of cell migration as it has been described in the study mentioned above . Human mesenchymal stem cells (hMSCs) have been used for the repair of osteochondral defects in rabbits by seeding them on biphasic composite constructs (hydroxyapatite + platelet-rich fibrin glue) for 4 and 8 weeks, respectively . It has been postulated in this study that the group where differentiated hMSCs have been used has shown superior healing of osteochondral defects first after 8 weeks . In vivo, fibrin will be gradually degraded during wound healing by fibrinolysis and replaced by the mature extracellular matrix, wherein the proteolytic activity of a membrane-type matrix metalloproteinases (MT1-MMP) [8, 9] and plasmin [10, 11] locally degrades the fibrin matrix. In vivo, this happens in a matter of days or weeks, and the rate of degradation depends on many factors such as fibrin structure, its cross-linking, and the incorporation of protease inhibitors [12–15]. Generally, the fibrin matrix is gradually replaced by mature collagen that is produced by invading cells [16–18]. In our study in vitro, there is a lack of such endogenous factors participating in the process of fibrinolysis, and one could therefore speculate that no invading cells have been found in the fibrin matrix. The insufficient degradation of fibrin and therefore scarce cell invasion could be the reason why no significant healing have been found after 4 weeks but first after 8 weeks as mentioned in the previously named study . Fibrin is gradually degraded in vivo as it was already explained in the text, and the healing process succeeds its degradation, leading to the new tissue formation eventually. The initial inhibition of cell invasion and therefore new tissue formation that we have seen in our in vitro model have therefore probably no effect on the final clinical outcome. Indeed, the authors of this text have used routinely the fibrin matrix in our cartilage repair techniques and have seen neither poor defect fill nor poor clinical results that could be related to the use of the fibrin matrix [19, 20].
We have not seen as well in our in vitro study that articular chondrocytes from undigested cartilage fragments have the capability to escape from the cartilage matrix and, by doing so, have an active role in new tissue formation. Whether they can do that in an in vivo situation under the influence of, for example, endogenous collagenases [21, 22], we can just speculate. It seems that when implanting autologous chondrocytes using fibrin as a carrier, the results look fairly good . On the other side, no tissue bonding or new cartilaginous tissue formation has been identified in the cartilage fragments without enzymatic treatment in a nude mice model . Finally, two studies have shown no cell invasion into the fibrin matrix , as well as direct influence of the pore size and fibrin strand thickness on the cell invasion . One recently done study has given even more evidence supporting our results in terms of chondrocyte outgrowth from adult human articular cartilage .
In summary, the results of our in vitro study do not speak in favor of an early induction of cartilage defect repair by these techniques using undigested particulated cartilage fragments embedded in fibrin. However, their final outcome could be influenced by many endogenous factors that might be found in an in vivo situation. As a final conclusion, the use of a fibrin matrix does not seem to promote cartilage repair processes due to its initial inhibition of cell migration, and it seems that enzymatic digestion of particulated cartilage fragments is a prerequisite for the chondrocyte migration out of the cartilage matrix.
The authors would like to thank Dr Johan Ljungqvist, Dr Maria Hilding, Malin Sjögren, and Nathalie Hanna for their technical assistance.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Cole BJ, Farr J, Winalski CS, Hosea T, Richmond J, Mandelbaum B, et al. Outcomes after a single-stage procedure for cell-based cartilage repair: a prospective clinical safety trial with 2-year follow-up. Am J Sports Med. 2011;39(6):1170–9.View ArticlePubMedGoogle Scholar
- Farr J, Cole BJ, Sherman S, Karas V. Particulated articular cartilage: CAIS and DeNovo NT. J Knee Surg. 2012;25(1):23–9.View ArticlePubMedGoogle Scholar
- Brittberg M. Autologous chondrocyte implantation—technique and long-term follow-up. Injury. 2008;39 Suppl 1:40–9.View ArticleGoogle Scholar
- Marmotti A, Bonasia DE, Bruzzone M, Rossi R, Castoldi F, Collo G, et al. Human cartilage fragments in a composite scaffold for single-stage cartilage repair: an in vitro study of the chondrocyte migration and the influence of TGF-β1 and G-CSF. Knee Surg Sports Traumatol Arthrosc. 2013;21(8):1819–33.View ArticlePubMedGoogle Scholar
- Kirilak Y, Pavlos NJ, Willers CR, Han R, Feng H, Xu J, et al. Fibrin sealant promotes migration and proliferation of human articular chondrocytes: possible involvement of thrombin and protease-activated receptors. Int J Mol Med. 2006;17(4):551–8.PubMedGoogle Scholar
- Marmotti A, Bruzzone M, Bonasia DE, Castoldi F, Rossi R, Piras L, et al. One-step osteochondral repair with cartilage fragments in a composite scaffold. Knee Surg Sports Traumatol Arthrosc. 2012;20(12):2590–601.View ArticlePubMedGoogle Scholar
- Jang KM, Lee JH, Park CM, Song HR, Wang JH. Xenotransplantation of human mesenchymal stem cells for repair of osteochondral defects in rabbits using osteochondral biphasic composite constructs. Knee Surg Sports Traumatol Arthrosc. 2013; [Epub ahead of print].Google Scholar
- Hiraoka N, Allen E, Apel IJ, Gyetko MR, Weiss SJ. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell. 1998;95(3):365–77.View ArticlePubMedGoogle Scholar
- Lafleur MA, Handsley MM, Knauper V, Murphy G, Edwards DR. Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs). J Cell Sci. 2002;115:3427–38.PubMedGoogle Scholar
- Pepper MS, Montesano R. Proteolytic balance and capillary morphogenesis. Cell Differ Dev. 1990;32(3):319–27.View ArticlePubMedGoogle Scholar
- van Hinsbergh VWM, Engelse MA, Quax PH. Pericellular proteases in angiogenesis and vasculogenesis. Arterioscler Thromb Vasc Biol. 2006;26(4):716–28.View ArticlePubMedGoogle Scholar
- Jockenhoevel S, Zund G, Hoerstrup SP, Chalabi K, Sachweh JS, Demircan L, et al. Fibrin gel: advantages of a new scaffold in cardiovascular tissue engineering. Eur J Cardiothorac Surg. 2001;19(4):424–30.View ArticlePubMedGoogle Scholar
- Gabriel DA, Muga K, Boothroyd EM. The effect of fibrin structure on fibrinolysis. J Biol Chem. 1992;267(34):24259–63.PubMedGoogle Scholar
- Linnes MP, Ratner BD, Giachelli CM. A fibrinogen-based precision microporous scaffold for tissue engineering. Biomaterials. 2007;28(35):5298–306.PubMed CentralView ArticlePubMedGoogle Scholar
- Medved LV, Gorkun OV, Manyakov VF, Belitser VA. The role of fibrinogen alpha C-domains in the fibrin assembly process. FEBS Lett. 1985;181(1):109–12.View ArticlePubMedGoogle Scholar
- Tuan TL, Song A, Chang S, Younai S, Nimni ME. In vitro fibroplasia: matrix contraction, cell growth, and collagen production of fibroblasts cultured in fibrin gels. Exp Cell Res. 1996;223(1):127–34.View ArticlePubMedGoogle Scholar
- Mol A, van Lieshout MI, Dam-de Veen CG, Neuenschwander S, Hoerstrup SP, Baaijens FP, et al. Fibrin as a cell carrier in cardiovascular tissue engineering applications. Biomaterials. 2005;26(16):3113–21.View ArticlePubMedGoogle Scholar
- Clark RA, Nielsen LD, Welch MP, McPherson JM. Collagen matrices attenuate the collagen-synthetic response of cultured fibroblasts to TGF-beta. J Cell Sci. 1995;108:1251–61.PubMedGoogle Scholar
- Schüttler S, Andjelkov N. Articular cartilage surgery in outpatients: a pilot study. J Knee Surg. 2011;24(2):125–7.View ArticlePubMedGoogle Scholar
- Schüttler S, Andjelkov N. Periosteal transplantation combined with AMIC technique in isolated patello-femoral osteoarthritis—a case report. Cartilage. 2012;3(2):194–8.PubMed CentralView ArticlePubMedGoogle Scholar
- Qu F, Lin JM, Esterhai JL, Fisher MB, Mauck RL. Biomaterial-mediated delivery of degradative enzymes to improve meniscus integration and repair. Acta Biomater. 2013;9(5):6393–402.PubMed CentralView ArticlePubMedGoogle Scholar
- Yoshida H, Kojima T, Kurokouchi K, Takahashi S, Hanamura H, Kojima M, et al. Relationship between pre-radiographic cartilage damage following anterior cruciate ligament injury and biomarkers of cartilage turnover in clinical practice: a cross-sectional observational study. Osteoarthritis Cartilage. 2013;21(6):831–8.View ArticlePubMedGoogle Scholar
- Kim MK, Choi SW, Kim SR, Oh IS, Won MH. Autologous chondrocyte implantation in the knee using fibrin. Knee Surg Sports Traumatol Arthrosc. 2010;18(4):528–34.View ArticlePubMedGoogle Scholar
- Liao CJ, Lin YJ, Chiang H, Chiang SF, Wang YH, Jiang CC. Injecting partially digested cartilage fragments into a biphasic scaffold to generate osteochondral composites in a nude mice model. J Biomed Mater Res A. 2007;81(3):567–77.View ArticlePubMedGoogle Scholar
- Brittberg M, Sjogren-Jansson E, Lindahl A, Peterson L. Influence of fibrin sealant (Tisseel) on osteochondral defect repair in the rabbit knee. Biomaterials. 1997;18(3):235–42.View ArticlePubMedGoogle Scholar
- Karp JM, Sarraf F, Shoichet MS, Davies JE. Fibrin-filled scaffolds for bone-tissue engineering. An in vivo study. J Biomed Mater Res A. 2004;71A:162–71.View ArticleGoogle Scholar
- Zingler C, Carl HD, Swoboda B, Krinner S, Hennig F, Gelse K. Limited evidence of chondrocyte outgrowth from adult human articular cartilage. Osteoarthritis Cartilage. 2015; doi: 10.1016/j.joca.2015.07.014. [Epub ahead of print]